My watch list
my.bionity.com  
Login  

Co-dydramol



Co-dydramol
Combination of
Dihydrocodeine Opioid analgesic
Paracetamol Non-opioid analgesic
Identifiers
CAS number  ?
ATC code  ?
PubChem  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes Oral

Co-dydramol (BAN) is a non-proprietary name used to denote a combination of dihydrocodeine tartrate and paracetamol. Co-dydramol tablets are used for the relief of moderate pain. Co-dydramol is in fact part of a series of combination drugs available in the UK and other countries including Co-codaprin (aspirin and codeine), Co-codamol (codeine phosphate and paracetamol) and Co-proxamol (dextropropoxyphene and paracetamol).

Formulation

All formulations contain 500 mg of paracetamol per tablet and may only be sold at a pharmacy as an over-the-counter item without prescription if containing less than 7.5 mg of dihydrocodeine per tablet. Higher strengths are prescription only medicines. Four strengths of dihydrocodeine tartrate in each tablet are available:

  • 7.46 mg dihydrocodeine in the brand Paramol.
  • 10 mg dihydrocodeine, BAN of Co-dydramol 10/500, this is also the preparation to be dispensed if no strength is specified on a prescription.
  • 20 mg dihydrocodeine, BAN of Co-dydramol 20/500 (branded product Remedeine).
  • 30 mg dihydrocodeine, BAN of Co-dydramol 30/500 (branded product Remedeine forte).

References

  • British National Formulary 2004
  • Merck Index 13th Edition
  • Oxford textbook of clinical pharmacology Second Edition (09. October 1992)
  • Martindale: The complete drug reference 35th Edition (2007)
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th Edition
 
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Co-dydramol". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE